MOVANTIK Trademark

Trademark Overview

On Friday, October 11, 2013, a trademark application was filed for MOVANTIK with the United States Patent and Trademark Office. The USPTO has given the MOVANTIK trademark a serial number of 86089235. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, December 3, 2024. This trademark is owned by AstraZeneca AB. The MOVANTIK trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations and substances for use in oncology; ] pharmaceutical preparations and substances for the treatment of [ cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, ] gastrointestinal [ diseases and ] disorders [, nervous system diseases and disorders, infection and inflammation ]
movantik

General Information

Serial Number86089235
Word MarkMOVANTIK
Filing DateFriday, October 11, 2013
Status800 - REGISTERED AND RENEWED
Status DateTuesday, December 3, 2024
Registration Number4600146
Registration DateTuesday, September 9, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2014

Trademark Statements

Goods and Services[ Pharmaceutical preparations and substances for use in oncology; ] pharmaceutical preparations and substances for the treatment of [ cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, ] gastrointestinal [ diseases and ] disorders [, nervous system diseases and disorders, infection and inflammation ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 19, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGR�NENTHAL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressAACHEN AACHEN
DE
Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, October 15, 2013NEW APPLICATION ENTERED
Friday, November 8, 2013TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, December 12, 2013ASSIGNED TO EXAMINER
Friday, December 13, 2013SUSPENSION LETTER WRITTEN
Friday, December 13, 2013LETTER OF SUSPENSION E-MAILED
Friday, December 13, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 7, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, October 19, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2013TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, February 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 7, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 1, 2014ASSIGNED TO LIE
Tuesday, March 4, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTICE OF PUBLICATION
Tuesday, June 3, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 16, 2014TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, July 16, 2014NOTICE OF ALLOWANCE CANCELLED
Monday, August 4, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 5, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 10, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 9, 2014REGISTERED-PRINCIPAL REGISTER
Monday, September 9, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 29, 2020TEAS SECTION 8 & 15 RECEIVED
Thursday, September 10, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 10, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 29, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, September 9, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, December 3, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 3, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, December 3, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, July 17, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 21, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 3, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

movantik diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal